Carboxypeptidase A: Difference between revisions

No edit summary
No edit summary
Line 40: Line 40:
==Catalytic and Inhibitory Zinc Binding==
==Catalytic and Inhibitory Zinc Binding==
[[Image:InhibitZn1CPX.png|150 px|left|thumb|Figure 4: Interaction between the inhibitory zinc and Glu270.  The inhibitory Zn<sup>2+</sup> ion is displayed in magenta.  Glu270 is shown explicitly in yellow.  The catalytic Zn<sup>2+</sup> ion (shown in cyan) is still being stabilized in place by His69, Glu72, and His196 (shown in orange).]]
[[Image:InhibitZn1CPX.png|150 px|left|thumb|Figure 4: Interaction between the inhibitory zinc and Glu270.  The inhibitory Zn<sup>2+</sup> ion is displayed in magenta.  Glu270 is shown explicitly in yellow.  The catalytic Zn<sup>2+</sup> ion (shown in cyan) is still being stabilized in place by His69, Glu72, and His196 (shown in orange).]]
CPA from ''B. taurus'' has been  co-crystallized with two Zn<sup>2+</sup> ions (Figure 1).  This structure has been deposited in the PDB database under the label [http://www.rcsb.org/pdb/explore/explore.do?structureId=1cpx 1CPX].  This is actually a β-form of CPA.  The binding of only one Zn<sup>2+</sup> ion is [http://en.wikipedia.org/wiki/Catalysis catalytic], while the binding of a second is [http://en.wikipedia.org/wiki/Reaction_inhibitor inhibitory].  These Zn<sup>2+</sup> ions are connected to each other via a hydroxy-bridge (Figure 3) with a distance of 3.48 [http://en.wikipedia.org/wiki/%C3%85ngstr%C3%B6m Å].<ref name="CPA1" />  [[Image:1CPXhydroxybridge.png|150 px|right|thumb|Figure 3: Hydroxy-bridge between catalytic and inhibitory zinc ions.  The catalytic Zn<sup>2+</sup> ion (shown in orange on the right) is bridged to the inhibitory Zn<sup>2+</sup> ion (shown in orange on the left) by a OH<sup>-</sup> (shown in red).]]  In the CPA structure containing only the catalytic Zn<sup>2+</sup> ion, a water molecule complexed to the zinc is able to be deprotonated by <scene name='69/694222/3cpas1subsiteglu270/1'>Glu270</scene> to allow for normal initiation of hydrolysis.  However, when the inhibitory Zn<sup>2+</sup> ion is also present, it occupies the physical space that would normally be occupied by the water molecule.  Thus, the inhibitory Zn<sup>2+</sup> ion interacts with the carboxylate group of Glu270.  The Glu270 now simply stabilizes the second zinc and is unable to perform its usual base catalyst role (Figure 4).
CPA from ''B. taurus'' has been  co-crystallized with two Zn<sup>2+</sup> ions (Figure 1).  This structure has been deposited in the PDB database under the label [http://www.rcsb.org/pdb/explore/explore.do?structureId=1cpx 1CPX], which is a β-form of CPA.  The binding of only one Zn<sup>2+</sup> ion is [http://en.wikipedia.org/wiki/Catalysis catalytic], while the binding of a second is [http://en.wikipedia.org/wiki/Reaction_inhibitor inhibitory].  These Zn<sup>2+</sup> ions are connected to each other via a hydroxy-bridge (Figure 3) with a distance of 3.48 [http://en.wikipedia.org/wiki/%C3%85ngstr%C3%B6m Å].<ref name="CPA1" />  [[Image:1CPXhydroxybridge.png|150 px|right|thumb|Figure 3: Hydroxy-bridge between catalytic and inhibitory zinc ions.  The catalytic Zn<sup>2+</sup> ion (shown in orange on the right) is bridged to the inhibitory Zn<sup>2+</sup> ion (shown in orange on the left) by a OH<sup>-</sup> (shown in red).]]  In the CPA structure containing only the catalytic Zn<sup>2+</sup> ion, a water molecule complexed to the zinc is able to be deprotonated by <scene name='69/694222/3cpas1subsiteglu270/1'>Glu270</scene> to allow for normal initiation of hydrolysis.  However, when the inhibitory Zn<sup>2+</sup> ion is also present, it occupies the physical space that would normally be occupied by the water molecule.  Thus, the inhibitory Zn<sup>2+</sup> ion interacts with the carboxylate group of Glu270.  The Glu270 now simply stabilizes the second zinc and is unable to perform its usual base catalyst role (Figure 4).


==Other Inhibitors==
==Other Inhibitors==

Proteopedia Page Contributors and Editors (what is this?)Proteopedia Page Contributors and Editors (what is this?)

Geoffrey C. Hoops, Michael Melbardis, Douglas Schnell, Thomas Baldwin, Michal Harel